Everolimus in Restoring Salivary Gland Function in Participants With Locally Advanced Head and Neck Cancer Treated With Radiation Therapy

Conditions:   Salivary Gland Dysfunction;   Xerostomia;   Head and Neck Cancer
Interventions:   Drug: Everolimus;   Other: Laboratory Biomarker Analysis;   Other: Survey Administration
Sponsors:   University of Arizona;   National Cancer Institute (NCI)
Recruiting

https://ift.tt/2MVsmbN